Page last updated: 2024-08-26

tandospirone and Cognition Disorders

tandospirone has been researched along with Cognition Disorders in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (44.44)29.6817
2010's5 (55.56)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Horiguchi, M; Meltzer, HY; Miyauchi, M; Neugebauer, NM; Oyamada, Y1
Massey, BW; Meltzer, HY; Michael, E; Rajagopal, L1
Bert, B; Bubenikova-Valesova, V; Horacek, J; Sumiyoshi, T1
Higuchi, Y; Ito, T; Kawasaki, Y; Seo, T; Sumiyoshi, T; Suzuki, M1
Adelekun, AE; Hannaway, KE; Horiguchi, M; Jayathilake, K; Meltzer, HY1
Cho, Y; Okubo, M1
Meltzer, HY; Sumiyoshi, T1
Ertugrul, A; Jayathilake, K; Meltzer, HY; Park, S; Roy, A; Sumiyoshi, T1
Jayathilake, K; Kurachi, M; Matsui, M; Meltzer, HY; Nohara, S; Sumiyoshi, C; Sumiyoshi, T; Yamashita, I1

Reviews

1 review(s) available for tandospirone and Cognition Disorders

ArticleYear
Serotonin1A receptors in the pathophysiology of schizophrenia: development of novel cognition-enhancing therapeutics.
    Advances in therapy, 2008, Volume: 25, Issue:10

    Topics: Animals; Behavior; Brain; Buspirone; Cognition Disorders; Humans; Isoindoles; Piperazines; Polymorphism, Genetic; Pyrimidines; Receptor, Serotonin, 5-HT1A; Schizophrenia; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists

2008

Trials

2 trial(s) available for tandospirone and Cognition Disorders

ArticleYear
Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: a randomized, double-blind, placebo-controlled study.
    Schizophrenia research, 2007, Volume: 95, Issue:1-3

    Topics: Adult; Ambulatory Care; Antipsychotic Agents; Buspirone; Cognition Disorders; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Isoindoles; Male; Neuropsychological Tests; Piperazines; Placebos; Pyrimidines; Schizophrenia; Schizophrenic Psychology; Serotonin Receptor Agonists; Treatment Outcome

2007
Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment.
    The American journal of psychiatry, 2001, Volume: 158, Issue:10

    Topics: Antipsychotic Agents; Cognition Disorders; Drug Therapy, Combination; Humans; Isoindoles; Piperazines; Pyrimidines; Schizophrenia; Schizophrenic Psychology; Serotonin Receptor Agonists; Treatment Outcome

2001

Other Studies

6 other study(ies) available for tandospirone and Cognition Disorders

ArticleYear
Prolonged reversal of the phencyclidine-induced impairment in novel object recognition by a serotonin (5-HT)1A-dependent mechanism.
    Behavioural brain research, 2016, Mar-15, Volume: 301

    Topics: Animals; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Isoindoles; Lurasidone Hydrochloride; Phencyclidine; Piperazines; Psychotropic Drugs; Pyridines; Pyrimidines; Random Allocation; Rats, Long-Evans; Receptor, Serotonin, 5-HT1A; Receptors, N-Methyl-D-Aspartate; Recognition, Psychology; Schizophrenic Psychology; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Time

2016
Serotonin (5-HT)1A receptor agonism and 5-HT7 receptor antagonism ameliorate the subchronic phencyclidine-induced deficit in executive functioning in mice.
    Psychopharmacology, 2016, Volume: 233, Issue:4

    Topics: Animals; Cognition Disorders; Executive Function; Isoindoles; Male; Mice; Mice, Inbred C57BL; Phencyclidine; Phenols; Piperazines; Pyrimidines; Reaction Time; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin; Reversal Learning; Serotonin 5-HT1 Receptor Agonists; Serotonin Antagonists; Sulfonamides

2016
Effect of tandospirone on mismatch negativity and cognitive performance in schizophrenia: a case report.
    Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:6

    Topics: Acoustic Stimulation; Adult; Cognition Disorders; Evoked Potentials; Female; Humans; Isoindoles; Piperazines; Pyrimidines; Schizophrenia; Schizophrenic Psychology; Serotonin 5-HT1 Receptor Agonists; Treatment Outcome

2010
Prevention of the phencyclidine-induced impairment in novel object recognition in female rats by co-administration of lurasidone or tandospirone, a 5-HT(1A) partial agonist.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2012, Volume: 37, Issue:10

    Topics: Animals; Cognition Disorders; Disease Models, Animal; Dopamine D2 Receptor Antagonists; Female; Haloperidol; Isoindoles; Lurasidone Hydrochloride; Phencyclidine; Piperazines; Piperidines; Pyridines; Pyrimidines; Rats; Rats, Long-Evans; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Agonists; Thiazoles; Urea

2012
[Anxiolytics, hypnotics].
    Nihon rinsho. Japanese journal of clinical medicine, 2012, Volume: 70 Suppl 6

    Topics: Adolescent; Aged; Anti-Anxiety Agents; Benzodiazepines; Child; Cognition Disorders; Female; Humans; Hypnotics and Sedatives; Isoindoles; Memory Disorders; Piperazines; Pregnancy; Pyrimidines; Selective Serotonin Reuptake Inhibitors

2012
Serotonin 1A receptors in memory function.
    The American journal of psychiatry, 2004, Volume: 161, Issue:8

    Topics: Cognition Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Hippocampus; Humans; Isoindoles; Memory; Memory Disorders; Piperazines; Pyrimidines; Receptor, Serotonin, 5-HT1A; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists; Serotonin Receptor Agonists

2004